|
| Publication | Subject | Indication for intracameral moxifloxacin | Moxifloxacin brand | Moxifloxacin dose | Other intra-op medications | Adverse effects (AEs) | Time to onset of AEs | Postoperative medications started prior to onset of AEs |
|
| Light and Falkenberry 2019 | 1 of 1 | Endophthalmitis prophylaxis for PPV for symptomatic floaters | Vigamox | 0.1 ml of 5 mg/ml | None | Decreased VA, AC flare, pigment dispersion in AC and angle, iris depigmentation, iris TID, elevated IOP | Post-op week 3 | Unspecified topical steroid, NSAID, fluoroquinolone |
| Peñaranda-Henao et al. 2020 | 1 of 1 | Endophthalmitis prophylaxis for cataract surgery | Unknown | Unknown | Unknown | Ocular pain, headache, elevated IOP, AC inflammation with keratic precipitates, pigment dispersion in the AC and angle, pupil deformation with poor reactivity, iris atrophy and TID, pigmented cells in the anterior vitreous, mild decrease in foveal brightness | Post-op week 2.5 | Oral acyclovir, intramuscular betamethasone, topical prednisolone acetate, topical timolol. Later, acyclovir was switched to valacyclovir |
| Sanchez-Sanchez et al. 2020 | 1 of 4 | Endophthalmitis prophylaxis for express shunt implantation for POAG | Vigamox | 0.1 ml of 5 mg/ml | Subconjunctival mitomycin C 0.2 mg/ml | Pigment dispersion in the AC, filtering bleb, and angle around the express shunt, mild mydriasis with sluggish light reaction | Post-op week 4 | Topical moxifloxacin, diclofenac sodium, predinoslone acetate |
| Sanchez-Sanchez et al. 2020 | 2 of 4 | Endophthalmitis prophylaxis for express shunt implantation for POAG | Vigamox | 0.1 ml of 5 mg/ml | Subconjunctival mitomycin C 0.2 mg/ml | Pigment dispersion in the AC and filtering bleb, fixed middilated pupil | Post-op week 2 | Topical moxifloxacin, diclofenac sodium, predinoslone acetate |
| Sanchez-Sanchez et al. 2020 | 3 of 4 | Endophthalmitis prophylaxis for deep non-penetrating sclerotomies with supraciliary hema implant for glaucoma | Vigamox | 0.1 ml of 5 mg/ml | Subconjunctival mitomycin C 0.2 mg/ml | Pigment dispersion in AC and on endothelium, mydriasis with poor light reaction, iris TID, elevated IOP at post op month 3 secondary to pigment obstruction of the trabeculo-Descemet membrane | Post-op week 4 | Topical moxifloxacin, diclofenac sodium, predinoslone acetate |
| Sanchez-Sanchez et al. 2020 | 4 of 4 | Endophthalmitis prophylaxis for deep non-penetrating sclerotomies with supraciliary hema implant for POAG | Vigamox | 0.1 ml of 5 mg/ml | Subconjunctival mitomycin C 0.2 mg/ml | Pigment dispersion under bleb, TID, irregular pupil | Post-op week 6 | Topical moxifloxacin, diclofenac sodium, predinoslone acetate |
| Zubicoa et al. 2020 | 1 of 1 | Endophthalmitis prophylaxis for cataract surgery | Vigamox | 0.1 ml of 5 mg/ml | Unknown | Eye pain, circumciliary congestion, pigment deposition on the IOL and in the angle, flare, mydriasis, iris TID | Post-op week 3.5 | Unspecified topical steroid |
|
